trial

Shared Decision Making for Antipsychotic Medications

NCTId NCT05416658
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 120 (estimated)
Sponsored by New York State Psychiatric Institute, Washington Heights Community Service
Primary completion 2027-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2027-01-01
Primary completion
2027-06-30
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
The Antipsychotic Medication Decision Aid (APM-DA)

Sponsors

New York State Psychiatric Institute, Washington Heights Community ServiceLead Sponsor
Temple University Collaborative on Community InclusionCollaborator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2027-06-30
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
The Antipsychotic Medication Decision Aid (APM-DA)
drug
lead_sponsor
New York State Psychiatric Institute, Washington Heights Community Service
company
collaborator
Temple University Collaborative on Community Inclusion
company
indication
Schizophreniform Disorders
indication
Schizoaffective Disorder
indication
Schizophrenia, Paranoid
indication